| Health Care Equipment & Supplies Industry | Healthcare Sector | Hirokazu Ogino CEO | OTC PINK Exchange | JP3706800004 ISIN |
| JP Country | 5,891 Employees | 29 Sep 2026 Last Dividend | 27 Jun 2024 Last Split | - IPO Date |
Nihon Kohden Corporation is a global enterprise based in Japan, dedicated to the development, manufacturing, sale, maintenance, and consultation of medical electronic equipment and related systems. Since its inception in 1951, it has expanded its reach beyond Japan, operating in the Americas, Europe, Asia, and other international markets. The company’s mission revolves around providing innovative medical solutions that enhance patient care and treatment outcomes. Nihon Kohden’s extensive portfolio serves various medical fields, affirming its commitment to advancing medical technology and support systems worldwide. In addition to its primary operations, Nihon Kohden engages in insurance brokerage and technology licensing, diversifying its contributions to the healthcare industry.
In this category, Nihon Kohden offers state-of-the-art devices such as electrocardiographs, electroencephalographs, and polygraphs specifically designed for Cath-labs. These tools are essential for diagnosing and monitoring the physiological functions of patients, aiding in the timely detection and management of medical conditions.
This includes both bedside and central monitors that provide continuous monitoring of patients’ vital signs and other health parameters. Nihon Kohden’s advanced patient monitoring systems are pivotal in critical care and general ward settings, enabling healthcare professionals to deliver timely interventions.
The range of treatment equipment from Nihon Kohden encompasses defibrillators, automated external defibrillators, ventilators, and pacemakers. These devices are crucial for emergency and routine treatments, offering life-saving and supportive therapies across various medical scenarios.
Nihon Kohden also offers diagnostic and clinical information systems that integrate and manage patient data from various sources. These systems enhance hospital workflow efficiency, patient management, and the accuracy of medical records, facilitating better clinical decision-making.
The company’s in-vitro diagnostic equipment, including hematology and clinical chemistry analyzers, plays an essential role in the laboratory diagnosis of diseases. These analyzers provide accurate and timely diagnostic information, supporting the effective treatment and management of patients.